Search

everythinglearnresearchcommunity

for

Search:↓

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Asia has made significant progress in tissue engineering and regenerative medicine, but wider clinical use requires more development.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

Spironolactone most effective for hirsutism, but has side effects.

The Wnt/β-catenin pathway is important for tissue development and has potential in regenerative medicine, but requires more research for therapeutic use.

Platelet-rich plasma might help tissue regeneration in dentistry, but results vary and more research is needed.

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Low-dose oral minoxidil and spironolactone combo effectively reduces hair loss and improves hair density in women.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Iron deficiency common in women, not always linked to hair loss; more research needed.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Finasteride helps reduce priapism in sickle cell anemia patients.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Certain drugs that block specific enzymes can help treat prostate diseases.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.